To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care.Crit Care Med. 2001; 29: 1303-1310
- The pathophysiology and treatment of sepsis.N Engl J Med. 2003; 348: 138-150
- The epidemiology of sepsis in the United States from 1979–2000.N Engl J Med. 2003; 348: 1546-1554
- Septic shock in pregnancy.Obstet Gynecol. 1997; 90: 553-561
- Double-blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock.Lancet. 1998; 351: 929-933
- Treating patients with severe sepsis.N Engl J Med. 1999; 340: 207-214
- Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med. 1992; 20: 864-874
- The 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med. 2003; 31: 1250-1256
- Epidemiology of sepsis syndrome in 8 academic medical centers: Academic Medical Center Consortium Sepsis Project Working Group.JAMA. 1997; 278: 234-240
- Therapeutic approaches to innate immunity: severe sepsis and septic shock.Nature Rev. 2003; 2: 635-645
- The crucial role of systemic responses in the innate (non-adaptive) host defense.J Endotoxin Res. 2001; 7: 327-332
- Depressed left ventricle performance: response to volume infusion in patients with sepsis and septic shock.Chest. 1988; 93: 903-910
- The PIRO concept: P is for predisposition.Crit Care Med. 2003; 7: 248-251
- New treatment strategies for severe sepsis and septic shock.Curr Opin Crit Care. 2003; 9: 390-396
- Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.JAMA. 1999; 282: 561-568
- New approaches to the treatment of sepsis.Clin Chest Med. 2003; 24: 521-548
- Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl J Med. 2001; 345: 1368-1377
- Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients.Am J Med. 1980; 68: 344-355
- Sepsis and septic shock.in: Braunwald E. Fauci A.S. Kasper D.L. Hauser S.L. Longo D.L. Jameson J.L. Harrison's principles of internal medicine. 15th edition. McGraw-Hill, New York2001: 799-804
- Consensus statement.Crit Care Med. 1997; 25: 910-925
- Dopamine treatment of spinal hypotension decreases uterine blood flow in the pregnant ewe.Anesthesiology. 1979; 51: 37-40
- Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.N Engl J Med. 2000; 342: 1301-1308
- The effects of high-dose corticosteroids in patients with septic shock: a prospective controlled study.N Engl J Med. 1984; 311: 1137-1143
- A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.N Engl J Med. 1987; 318: 653-658
- Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.N Engl J Med. 1987; 317: 659-665
- Steroid controversy in sepsis and septic shock: meta-analysis.Crit Care Med. 1995; 23: 1294-1303
- Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.JAMA. 2002; 288: 862-871
- Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med. 2001; 344: 699-709
- Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial.JAMA. 2001; 286: 1869-1878
- Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.Crit Care Med. 2000; 28: S31-S33
- Review committee recommends termination of phase 3 study of Pafase—rPAF-AH—in severe sepsis.(Available at:) (Accessed February 13, 2003)
- Intensive insulin therapy in critically ill patients.N Engl J Med. 2001; 345: 1359-1367
- Infection control in the ICU.Chest. 2001; 120: 2059-2093
- Septic shock.Tech Bull. 1996; 204
Article info
Identification
Copyright
© 2004 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
